DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part of the
legislative instrument. The keyword, one-liner, abstract, and digest do not constitute part of the law
or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
HB 815 Original 2024 Regular Session Billings
Abstract: Requires the La. Dept. of Health (LDH) to ensure that all descriptive advertising and
promotional material relating to drugs, pharmaceuticals, medical treatments, or vaccinations follow
certain federal laws and rules.
Proposed law requires LDH to ensure that all descriptive advertising and promotional material
relating to drugs, pharmaceuticals, medical treatments, or vaccinations follow certain federal laws
and rules.
Proposed law provides that the federal rules and regulations relative to commercial advertisement
shall apply.
Proposed law provides that notice of noncompliance shall be given to the manufacturer of the drug,
pharmaceutical, medical treatment, or vaccine-related advertisement or promotional material within
30 days of the publication or broadcast of such noncompliant advertisements or promotional
material.
Proposed law further requires the manufacturer to remedy its noncompliance within 30 days of
receiving notice. If, after notice has been received and the 30-day period has lapsed, the drug,
pharmaceutical, medical treatment, or vaccine-related advertisement or promotional material shall
be subject to immediate removal from publication and broadcast if it continues to be noncompliant.
Proposed law requires LDH to produce only advertisements and promotional materials that comply
with the provisions of proposed law and federal regulations.
Proposed law requires LDH to use existing staff and promulgate rules as necessary to carry out the
provisions of proposed law.
(Adds R.S. 40:1176.1)